Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial

NCT06278779 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT06278779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Recruiting
Start date
June 3, 2024
Completion date
April 30, 2027
Enrollment
162 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression